Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
i3 Drug Safety
Basking Ridge, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
i3 Drug Safety was a specialized business unit within i3, a global contract research organization (CRO) that provided a wide range of clinical development services. The division focused specifically on pharmacovigilance, drug safety monitoring, and risk management services for pharmaceutical and biotechnology companies. i3 was originally a part of Ingenix, a subsidiary of UnitedHealth Group, before the broader i3 CRO business was acquired by inVentiv Health in 2011. Today, the legacy operations of i3 Drug Safety are integrated into Syneos Health following the merger of inVentiv Health and INC Research.
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on i3 Drug Safety.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on i3 Drug Safety.